• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
Scope It Out
MENU 
  • Home
  • About IFAR
  • About Dr. Smith
  • Episodes
  • Subscribe

frontal sinusotomy

Episode 97: Rate of dupilumab use and symptom severity of patients with chronic rhinosinusitis with nasal polyposis after Draf 3 frontal sinusotomy

February 11, 2025

In this episode, host Dr. Doug Reh speaks with Dr. Mathew Geltzeiler. They discuss the recently published Original Article: “Rate of dupilumab use and symptom severity of patients with chronic rhinosinusitis with nasal polyposis after Draf 3 frontal sinusotomy”. The full manuscript is available online in the International Forum of Allergy and Rhinology.

Listen and subscribe for free to Scope It Out on Apple Podcasts, Google Podcasts and Subscribe on Android.

Scope It Out
Scope It Out
Episode 97: Rate of dupilumab use and symptom severity of patients with chronic rhinosinusitis with nasal polyposis after Draf 3 frontal sinusotomy
Loading
00:00 / 19:58
Apple Podcasts
RSS Feed
Share
Link
Embed

Download file | Play in new window | Duration: 19:58 | Recorded on February 11, 2025

Subscribe: Apple Podcasts

Tagged With: biological products, chronic rhinosinusitis, dupilumab, endoscopy, frontal sinusotomy, medical therapy of chronic rhinosinusitis, nasal polyps, sinusitis, SNOT-22

Primary Sidebar

Visit Our Partners

American Academy of Otolaryngic AllergyInternational Forum of Allergy and RhinologyThe American Rhinologic Society

Sponsors

       Storz

  • Help & Support
  • About Us
  • Contact Us
  • Cookies & Privacy
  • Wiley Job Network
  • Cookie Preferences
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
Wiley